Why NovoCure stock fell today? TTFields data (NASDAQ:NVCR)

0


crash of the stock exchanges

franckreporter

Shares of NovoCure Limited (NASDAQ:NVCR) reached a 52-week low on Tuesday after the medical device maker and its China-based partner Zai Lab (ZLAB) posted late-stage data for their cancer treatment device, Tumor Treating Fields (TTFields), in patients with lung cancer.



Source link

Leave A Reply

Your email address will not be published.